|Articles|November 1, 2019
- Pharmaceutical Executive-11-01-2019
- Volume 39
- Issue 11
Pharmaceutical Executive, November 2019 Issue (PDF)
Click the title above to open the Pharmaceutical Executive November 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 6 years ago
Pharm Exec’s 2020 Pipeline Reportalmost 6 years ago
R. Jude Samulski: Gene Therapy’s Guiding Forcealmost 6 years ago
The Pace of Massive Innovationalmost 6 years ago
The Quest to Measure Drug Effectivenessalmost 6 years ago
Biosensors in Pharma: A Dose of Optimismalmost 6 years ago
Closing the Science and Manufacturing Dividealmost 6 years ago
Country Report: SwedenNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
What Impact will TrumpRx and Other DTC Programs Have on Drug Availability?
2
EMD Serono Announces Agreement with Trump Administration Increasing Access to In Vitro Fertilization Therapies for US Patients
3
Eli Lilly’s and Novo’s Stocks React to President Trump’s Comments on GLP-1 Prices
4
Autonomous Omnichannel: When AI Thinks for Pharma Marketing
5
